Testing dapagliflozin before surgery for early stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests the safety of dapagliflozin (a diabetes drug) taken before surgery for stage IA lung adenocarcinoma. It may help understand if this drug can slow tumor growth while waiting for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 22 years old
- You must have stage IA lung adenocarcinoma and be scheduled for surgery
- You must have a tumor sample available for testing
- You must be willing to have an extra CT-guided lung biopsy for research
- Your kidney and liver function must be within certain limits
- You cannot be pregnant or breastfeeding, and must use birth control if applicable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving two immunotherapy drugs directly into the tumor before surgery can shrink non-small cell lung cancer and improve outcomes. It is for people with early-stage (IIIA) lung cancer who are candidates for surgery.
This study tests whether a medicine typically used for diabetes or weight loss (a GLP-1 drug) can help reduce side effects from the lung cancer drug lorlatinib. If you are already taking lorlatinib for your ALK-positive lung cancer and have not used a GLP-1 drug recently, you might be able to join.
This trial tests whether giving new drugs (amivantamab plus either lazertinib or chemotherapy) before surgery helps people with a specific type of lung cancer that can be removed. The goal is to shrink tumors and improve surgery outcomes.
This trial tests whether adding the drug dapagliflozin (a pill that lowers blood sugar) to standard chemotherapy before breast cancer surgery can improve outcomes. It is for women with high insulin levels and a higher BMI who are about to start chemotherapy.
This trial tests whether taking lazertinib before surgery can shrink or control EGFR-mutant lung adenocarcinoma that can be fully removed by an operation. It uses a special liquid biopsy from fluid in the lungs to confirm the EGFR mutation and guide treatment.
This trial tests if the diabetes drug dapagliflozin can protect the heart in people with breast cancer receiving a type of chemotherapy called anthracyclines. You may be able to join if you are between 18 and 80, have stage I-III breast cancer, and are about to start anthracycline treatment within the next 60 days.
Hear when a new Stage IA2 Lung Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.